DDInter783 DDInter1082
Fosphenytoin is a water-soluble phenytoin prodrug used only in hospitals for the treatment of epileptic seizures. It works by slowing down impulses in the brain that cause seizures. Its main mechanism is to block frequency-dependent, use-dependent and voltage-dependent neuronal sodium channels, and therefore limit repetitive firing of action potentials.
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type II diabetes mellitus (T2DM). It is sold by Sanofi-Aventis under the brand name Adlyxin in the US and Lyxumia in the EU. Adlyxin recieved FDA approval July 28, 2016.
Fosphenytoin {u} (Compound) resembles {v} (Compound) Modafinil
Fosphenytoin {u} (Compound) resembles {v} (Compound) Methylphenobarbital
Fosphenytoin {u} (Compound) treats {v} (Disease) epilepsy syndrome
Fosphenytoin {u} (Compound) binds {v} (Gene) CYP2C9
Fosphenytoin {u} (Compound) is included by {v} (Pharmacologic Class) Decreased Central Nervous System Disorganized Electrical Activity
Fosphenytoin {u} (Compound) causes {v} (Side Effect) Encephalopathy
Fosphenytoin {u} may cause a minor interaction that can limit clinical effects when taken with {v} Acetylsalicylic acid
Fosphenytoin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Afatinib
Fosphenytoin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Acetohexamide
Fosphenytoin {u} may lead to a major life threatening interaction when taken with {v} Apremilast
Fosphenytoin (Compound) resembles Modafinil (Compound)
Fosphenytoin (Compound) resembles Methylphenobarbital (Compound)
Fosphenytoin (Compound) treats epilepsy syndrome (Disease)
Fosphenytoin (Compound) binds CYP2C9 (Gene)
Fosphenytoin (Compound) is included by Decreased Central Nervous System Disorganized Electrical Activity (Pharmacologic Class)
Fosphenytoin (Compound) causes Encephalopathy (Side Effect)
Fosphenytoin may cause a minor interaction that can limit clinical effects when taken with Acetylsalicylic acid
Fosphenytoin may cause a moderate interaction that could exacerbate diseases when taken with Afatinib
Fosphenytoin may cause a moderate interaction that could exacerbate diseases when taken with Acetohexamide
Fosphenytoin may lead to a major life threatening interaction when taken with Apremilast